Oral modified release formulations

Details Oral modified release formulations Oral modified release formulations

A - Human Necessities

61

K

A61K 9/20 (2006.01) A61K 31/35 (2006.01) A61K 31/565 (2006.01)

Patent

CA 2662956

This invention is directed to an oral modified release formulation of the phytoestrogen 8-Prenylnaringenin in combination with a progestin, preferably with Drospirenone, and several uses thereof. In another aspect of the invention an oral modified formulation of 8- Prenylnaringenin with an immediately releasing progestin, like Drospirenone, is provided as well as several uses thereof.

La présente invention concerne une formulation orale à libration modifiée du phytoestrogène 8-prénylnaringénine en association avec une progestine, de préférence avec la drospirénone, et plusieurs utilisations de cette formulation. Selon un autre aspect, l'invention concerne une formulation orale modifiée de 8-drénylnaringénine avec une progestine à libération immédiate, telle que la drospirénone ainsi que plusieurs utilisations de ladite formulation.

Affiliated with

Also associated with

Rating

Oral modified release formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral modified release formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral modified release formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1762427